{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:24:40Z","timestamp":1787271880868,"version":"build-2736575974"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["QY24326"],"award-info":[{"award-number":["QY24326"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271156"],"award-info":[{"award-number":["32271156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01526-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:39:14Z","timestamp":1781501954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-Adrenergic receptors as immunomodulators in T cells: mechanisms of neuroimmune crosstalk and pathophysiological implications"],"prefix":"10.1186","volume":"32","author":[{"given":"Junyan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"4","key":"1526_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/ph18040493","volume":"18","author":"H Abbes","year":"2025","unstructured":"Abbes H, Soria-Chacartegui P, Omezzine A, Abad-Santos F, Zubiaur P. Impact of genetic variation in adrenergic receptors on \u03b2-blocker effectiveness and safety in cardiovascular disease management: A systematic review. Pharmaceuticals. 2025;18(4):493. https:\/\/doi.org\/10.3390\/ph18040493.","journal-title":"Pharmaceuticals"},{"key":"1526_CR2","doi-asserted-by":"publisher","first-page":"1759720X2110090","DOI":"10.1177\/1759720X211009020","volume":"13","author":"AY Abuhelwa","year":"2021","unstructured":"Abuhelwa AY, Foster DJR, Manning-Bennett A, Sorich MJ, Proudman S, Wiese MD, et al. Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: A post hoc multicohort analysis. Ther Adv Musculoskelet Dis. 2021;13:1759720X211009020. https:\/\/doi.org\/10.1177\/1759720X211009020. PubMed PMID: 33912249; PubMed Central PMCID: PMC8047969.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1526_CR3","doi-asserted-by":"crossref","unstructured":"Albelo-Mart\u00ednez M, Rizvi S. Progressive multiple sclerosis: Evaluating current therapies and exploring future treatment strategies. Neurotherapeutics. 2025;e0060110.1016\/j.neurot.2025.e00601.","DOI":"10.1016\/j.neurot.2025.e00601"},{"issue":"1","key":"1526_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13041-024-01077-7","volume":"17","author":"R Amoriello","year":"2024","unstructured":"Amoriello R, Memo C, Ballerini L, Ballerini C. The brain cytokine orchestra in multiple sclerosis: From neuroinflammation to synaptopathology. Mol Brain. 2024;17(1):4. https:\/\/doi.org\/10.1186\/s13041-024-01077-7.","journal-title":"Mol Brain"},{"issue":"9","key":"1526_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/cncr.31943","volume":"125","author":"MH Antoni","year":"2019","unstructured":"Antoni MH, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer. 2019;125(9):1417\u201331. https:\/\/doi.org\/10.1002\/cncr.31943.","journal-title":"Cancer"},{"issue":"12","key":"1526_CR6","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.celrep.2019.08.042","volume":"28","author":"LP Araujo","year":"2019","unstructured":"Araujo LP, Maricato JT, Guereschi MG, Takenaka MC, Nascimento VM, De Melo FM, et al. The sympathetic nervous system mitigates CNS autoimmunity via \u03b22-adrenergic receptor signaling in immune cells. Cell Rep. 2019;28(12):3120\u2013e31305. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.042.","journal-title":"Cell Rep"},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3389\/fimmu.2019.03082","volume":"10","author":"FL Baker","year":"2020","unstructured":"Baker FL, Bigley AB, Agha NH, Pedlar CR, O\u2019Connor DP, Bond RA, et al. Systemic \u03b2-adrenergic receptor activation augments the ex vivo expansion and anti-tumor activity of V\u03b39V\u03b42 T-cells. Front Immunol. 2020;10:3082. https:\/\/doi.org\/10.3389\/fimmu.2019.03082.","journal-title":"Front Immunol"},{"issue":"1","key":"1526_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri.2017.99","volume":"18","author":"GR Bantug","year":"2018","unstructured":"Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol. 2018;18(1):19\u201334. https:\/\/doi.org\/10.1038\/nri.2017.99.","journal-title":"Nat Rev Immunol"},{"key":"1526_CR9","doi-asserted-by":"publisher","unstructured":"Bathe-Peters M, Gmach P, Boltz HH, Einsiedel J, Gotthardt M, H\u00fcbner H et al. Visualization of \u03b2-adrenergic receptor dynamics and differential localization in cardiomyocytes. Proceedings of the National Academy of Sciences. 2021;118(23):e2101119118. https:\/\/doi.org\/10.1073\/pnas.2101119118","DOI":"10.1073\/pnas.2101119118"},{"issue":"1","key":"1526_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-101819-024752","volume":"42","author":"HN Bell","year":"2024","unstructured":"Bell HN, Zou W. Beyond the barrier: Unraveling the mechanisms of immunotherapy resistance. Annu Rev Immunol. 2024;42(1):521\u201350. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-024752.","journal-title":"Annu Rev Immunol"},{"key":"1526_CR11","doi-asserted-by":"publisher","unstructured":"Bellinger DL, Lorton D. Autonomic regulation of cellular immune function. Autonomic Neuroscience. 2014;Special issue on Autonomic Nervous System and Inflammation182:15\u201341. https:\/\/doi.org\/10.1016\/j.autneu.2014.01.006","DOI":"10.1016\/j.autneu.2014.01.006"},{"issue":"4","key":"1526_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms19041188","volume":"19","author":"DL Bellinger","year":"2018","unstructured":"Bellinger DL, Lorton D. Sympathetic nerve hyperactivity in the spleen: Causal for nonpathogenic-driven chronic immune-mediated inflammatory diseases (IMIDs)? Int J Mol Sci. 2018;19(4):4. https:\/\/doi.org\/10.3390\/ijms19041188.","journal-title":"Int J Mol Sci"},{"key":"1526_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbi.2023.06.020","volume":"113","author":"N Ben-Shalom","year":"2023","unstructured":"Ben-Shalom N, Sandbank E, Abramovitz L, Hezroni H, Levine T, Trachtenberg E, Brain, et al. Behav Immun. 2023;113:66\u201382. https:\/\/doi.org\/10.1016\/j.bbi.2023.06.020.","journal-title":"Behav Immun"},{"issue":"2","key":"1526_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/brbi.1996.0009","volume":"10","author":"RJ Benschop","year":"1996","unstructured":"Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M, Brain. Behav Immun. 1996;10(2):77\u201391. https:\/\/doi.org\/10.1006\/brbi.1996.0009.","journal-title":"Behav Immun"},{"key":"1526_CR15","doi-asserted-by":"publisher","unstructured":"Blair AB, Jurcak NR, Javed A, Teinor J, Groot VP, Rozich N, et al. Nonselective \u03b2-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival. Annals Pancreat Cancer. 2020;3(0). https:\/\/doi.org\/10.21037\/apc-19-45.","DOI":"10.21037\/apc-19-45"},{"issue":"8022","key":"1526_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","volume":"631","author":"M Bosch","year":"2024","unstructured":"Bosch M, Kallin N, Donakonda S, Zhang JD, Wintersteller H, Hegenbarth S, et al. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection. Nature. 2024;631(8022):867\u201375. https:\/\/doi.org\/10.1038\/s41586-024-07630-7.","journal-title":"Nature"},{"issue":"6","key":"1526_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41417-023-00599-x","volume":"30","author":"G Bruno","year":"2023","unstructured":"Bruno G, Nastasi N, Subbiani A, Boaretto A, Ciullini Mannurita S, Mattei G, et al. \u03b23-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-\u03b3-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. Cancer Gene Ther. 2023;30(6):890\u2013904. https:\/\/doi.org\/10.1038\/s41417-023-00599-x.","journal-title":"Cancer Gene Ther"},{"issue":"20","key":"1526_CR19","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, et al. \u03b2-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8\u2009+\u2009T cells and undermines checkpoint inhibitor therapy. Cancer Res. 2017;77(20):5639\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0546.","journal-title":"Cancer Res"},{"issue":"2","key":"1526_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/aja.1001620207","volume":"162","author":"K Bulloch","year":"1981","unstructured":"Bulloch K, Moore RY. Innervation of the thymus gland by brain stem and spinal cord in mouse and rat. Am J Anat. 1981;162(2):157\u201366. https:\/\/doi.org\/10.1002\/aja.1001620207.","journal-title":"Am J Anat"},{"issue":"1","key":"1526_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cne.902280107","volume":"228","author":"K Bulloch","year":"1984","unstructured":"Bulloch K, Pomerantz W. Autonomic nervous system innervation of thymic-related lymphoid tissue in wildtype and nude mice. J Comp Neurol. 1984;228(1):57\u201368. https:\/\/doi.org\/10.1002\/cne.902280107.","journal-title":"J Comp Neurol"},{"issue":"10","key":"1526_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00392-010-0162-6","volume":"99","author":"D Bulut","year":"2010","unstructured":"Bulut D, Scheeler M, Wichmann T, B\u00f6rgel J, Miebach T, M\u00fcgge A. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol. 2010;99(10):633\u20138. https:\/\/doi.org\/10.1007\/s00392-010-0162-6.","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"1526_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11910-024-01382-7","volume":"24","author":"E C\u00e1ceres","year":"2024","unstructured":"C\u00e1ceres E, Olivella JC, Di Napoli M, Raihane AS, Divani AA. Immune response in traumatic brain injury. Curr Neurol Neurosci Rep. 2024;24(12):593\u2013609. https:\/\/doi.org\/10.1007\/s11910-024-01382-7.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1526_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1196\/annals.1351.006","volume":"1069","author":"E Calcagni","year":"2006","unstructured":"Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci. 2006;1069(1):62\u201376. https:\/\/doi.org\/10.1196\/annals.1351.006.","journal-title":"Ann N Y Acad Sci"},{"key":"1526_CR25","doi-asserted-by":"publisher","unstructured":"Calvani M, Dabraio A, Subbiani A, Buonvicino D, De Gregorio V, Ciullini Mannurita S, et al. \u03b23-adrenoceptors as putative regulator of immune tolerance in cancer and pregnancy. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.02098.","DOI":"10.3389\/fimmu.2020.02098"},{"issue":"2","key":"1526_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0889-1591(03)00026-6","volume":"17","author":"L Cao","year":"2003","unstructured":"Cao L, Hudson CA, Lawrence DA. Acute cold\/restraint stress inhibits host resistance to listeria monocytogenes via \u03b21-adrenergic receptors. Brain Behav Immun. 2003;17(2):121\u201333. https:\/\/doi.org\/10.1016\/S0889-1591(03)00026-6.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1526_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.fmre.2022.03.002","volume":"3","author":"Y Cao","year":"2023","unstructured":"Cao Y, Liu T, Zhou X, Fu W, Li J, Yang J. 3D anatomy of autonomic innervations in immune organs of a non-human primate and the human. Fundamental Res. 2023;3(2):249\u201356. https:\/\/doi.org\/10.1016\/j.fmre.2022.03.002.","journal-title":"Fundamental Res"},{"key":"1526_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbi.2021.02.030","volume":"94","author":"T Carandini","year":"2021","unstructured":"Carandini T, Cercignani M, Galimberti D, Scarpini E, Bozzali M, Brain. Behav Immun. 2021;94:381\u201391. https:\/\/doi.org\/10.1016\/j.bbi.2021.02.030.","journal-title":"Behav Immun"},{"issue":"18","key":"1526_CR31","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/febs.14166","volume":"284","author":"CM Carvajal Gonczi","year":"2017","unstructured":"Carvajal Gonczi CM, Tabatabaei Shafiei M, East A, Martire E, Maurice-Ventouris MHI, Darlington PJ. Reciprocal modulation of helper Th1 and Th17 cells by the \u03b22-adrenergic receptor agonist drug terbutaline. FEBS J. 2017;284(18):3018\u201328. https:\/\/doi.org\/10.1111\/febs.14166.","journal-title":"FEBS J"},{"issue":"10","key":"1526_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.humimm.2023.06.007","volume":"84","author":"CM Carvajal Gonczi","year":"2023","unstructured":"Carvajal Gonczi CM, Hajiaghayi M, Gholizadeh F, Xavier Soares MA, Touma F, Lopez Naranjo C, et al. The \u03b22-adrenergic receptor agonist terbutaline upregulates T helper-17 cells in a protein kinase A-dependent manner. Hum Immunol. 2023;84(10):515\u201324. https:\/\/doi.org\/10.1016\/j.humimm.2023.06.007.","journal-title":"Hum Immunol"},{"issue":"3","key":"1526_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10238-022-00842-z","volume":"23","author":"H Chang","year":"2023","unstructured":"Chang H, Lee SH. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: A systemic review and meta-analysis. Clin Exp Med. 2023;23(3):853\u20138. https:\/\/doi.org\/10.1007\/s10238-022-00842-z.","journal-title":"Clin Exp Med"},{"issue":"3","key":"1526_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.immuni.2020.07.012","volume":"53","author":"D Chang","year":"2020","unstructured":"Chang D, Xing Q, Su Y, Zhao X, Xu W, Wang X, et al. The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced rorc transcription during T helper 17 cell differentiation. Immunity. 2020;53(3):614\u2013e6264. https:\/\/doi.org\/10.1016\/j.immuni.2020.07.012.","journal-title":"Immunity"},{"issue":"2","key":"1526_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0165-5728(89)90138-0","volume":"25","author":"E Chelmicka-Schorr","year":"1989","unstructured":"Chelmicka-Schorr E, Kwasniewski MN, Thomas BE, Arnason BGW. The \u03b2-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol. 1989;25(2):203\u20137. https:\/\/doi.org\/10.1016\/0165-5728(89)90138-0.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1526_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41420-021-00735-2","volume":"7","author":"H Chen","year":"2021","unstructured":"Chen H, Cao N, Wang L, Wu Y, Wei H, Li Y, et al. Biased activation of \u03b22-AR\/gi\/GRK2 signal pathway attenuated \u03b21-AR sustained activation induced by \u03b21-adrenergic receptor autoantibody. Cell Death Discov. 2021;7(1):340. https:\/\/doi.org\/10.1038\/s41420-021-00735-2.","journal-title":"Cell Death Discov"},{"key":"1526_CR36","doi-asserted-by":"publisher","first-page":"217817","DOI":"10.1016\/j.canlet.2025.217817","volume":"625","author":"X Chen","year":"2025","unstructured":"Chen X, Cao Y, Zhao Y, Ma Y, Shi X, Wang J, et al. Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression. Cancer Lett. 2025;625:217817. https:\/\/doi.org\/10.1016\/j.canlet.2025.217817.","journal-title":"Cancer Lett"},{"issue":"9","key":"1526_CR37","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi H, Pepper M, Thomas PG. Principles and therapeutic applications of adaptive immunity. Cell. 2024;187(9):2052\u201378. https:\/\/doi.org\/10.1016\/j.cell.2024.03.037.","journal-title":"Cell"},{"issue":"1","key":"1526_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-021-00137-1","volume":"9","author":"F Concei\u00e7\u00e3o","year":"2021","unstructured":"Concei\u00e7\u00e3o F, Sousa DM, Paredes J, Lamghari M. Sympathetic activity in breast cancer and metastasis: Partners in crime. Bone Res. 2021;9(1):1\u201311. https:\/\/doi.org\/10.1038\/s41413-021-00137-1.","journal-title":"Bone Res"},{"key":"1526_CR39","doi-asserted-by":"publisher","unstructured":"Constantinescu V, Haase R, Akg\u00fcn K, Ziemssen T. Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1431380.","DOI":"10.3389\/fphar.2024.1431380"},{"issue":"11","key":"1526_CR40","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","volume":"7","author":"C Daher","year":"2019","unstructured":"Daher C, Vimeux L, Stoeva R, Peranzoni E, Bismuth G, Wieduwild E, et al. Blockade of \u03b2-adrenergic receptors improves CD8\u2009+\u2009T-cell priming and cancer vaccine efficacy. Cancer Immunol Res. 2019;7(11):1849\u201363. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0833.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1526_CR41","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-024-47096-9","volume":"15","author":"S Daneshmandi","year":"2024","unstructured":"Daneshmandi S, Choi JE, Yan Q, MacDonald CR, Pandey M, Goruganthu M, et al. Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies. Nat Commun. 2024;15(1):2803. https:\/\/doi.org\/10.1038\/s41467-024-47096-9.","journal-title":"Nat Commun"},{"issue":"2","key":"1526_CR42","doi-asserted-by":"publisher","first-page":"e172908","DOI":"10.1001\/jamaoncol.2017.2908","volume":"4","author":"V De Giorgi","year":"2018","unstructured":"De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, et al. Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study. JAMA Oncol. 2018;4(2):e172908. https:\/\/doi.org\/10.1001\/jamaoncol.2017.2908.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1526_CR43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.immuni.2021.03.025","volume":"54","author":"S Devi","year":"2021","unstructured":"Devi S, Alexandre YO, Loi JK, Gillis R, Ghazanfari N, Creed SJ, et al. Adrenergic regulation of the vasculature impairs leukocyte interstitial migration and suppresses immune responses. Immunity. 2021;54(6):1219\u2013e12307. https:\/\/doi.org\/10.1016\/j.immuni.2021.03.025.","journal-title":"Immunity"},{"issue":"2","key":"1526_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07","volume":"127","author":"ES Diaz","year":"2012","unstructured":"Diaz ES, Karlan BY, Li AJ. Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol. 2012;127(2):375\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2012.07. 102 PubMed PMID: 22819786.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1526_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms23052847","volume":"23","author":"P Dobosz","year":"2022","unstructured":"Dobosz P, St\u0119pie\u0144 M, Golke A, Dzieci\u0105tkowski T. Challenges of the immunotherapy: Perspectives and limitations of the immune checkpoint inhibitor treatment. Int J Mol Sci. 2022;23(5):5. https:\/\/doi.org\/10.3390\/ijms23052847.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1526_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12272-020-01280-9","volume":"44","author":"D Dorotea","year":"2021","unstructured":"Dorotea D, Ha H. Activation of \u03b22 adrenergic receptor signaling modulates inflammation: A target limiting the progression of kidney diseases. Arch Pharm Res. 2021;44(1):49\u201362. https:\/\/doi.org\/10.1007\/s12272-020-01280-9.","journal-title":"Arch Pharm Res"},{"issue":"12","key":"1526_CR48","doi-asserted-by":"publisher","first-page":"e52911","DOI":"10.1371\/journal.pone.0052911","volume":"7","author":"Y Du","year":"2012","unstructured":"Du Y, Yan L, Wang J, Zhan W, Song K, Han X, et al. \u03b21-adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the \u03b21-AR\/cAMP\/PKA and p38 MAPK pathways. Hirsch E, editor. PLoS ONE. 2012;7(12):e52911. https:\/\/doi.org\/10.1371\/journal.pone.0052911.","journal-title":"PLoS ONE"},{"issue":"2","key":"1526_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10557-019-06856-2","volume":"33","author":"Y Du","year":"2019","unstructured":"Du Y, Li X, Yu H, Yan L, Lau WB, Zhang S, et al. Activation of T lymphocytes as a novel mechanism in Beta1-adrenergic receptor autoantibody-induced cardiac remodeling. Cardiovasc Drugs Ther. 2019a;33(2):149\u201361. https:\/\/doi.org\/10.1007\/s10557-019-06856-2.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"1526_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbrc.2019.01.072","volume":"510","author":"Y Du","year":"2019","unstructured":"Du Y, Zhang S, Hao W, Xu W, Yan L, Liu H. Pro-remodeling effect of autoantibody against \u03b21-adrenoceptor on cardiomyocytes involves T cells dysfunction under the pathological condition of heart failure. Biochem Biophys Res Commun. 2019b;510(1):163\u201370. https:\/\/doi.org\/10.1016\/j.bbrc.2019.01.072.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1526_CR50","doi-asserted-by":"publisher","first-page":"e010475","DOI":"10.1161\/JAHA.118.010475","volume":"8","author":"Y Du","year":"2019","unstructured":"Du Y, Zhang S, Yu H, Wu Y, Cao N, Wang W, et al. Autoantibodies against \u03b21-adrenoceptor exaggerated ventricular remodeling by inhibiting CTRP9 expression. J Am Heart Association. 2019c;8(4):e010475. https:\/\/doi.org\/10.1161\/JAHA.118.010475.","journal-title":"J Am Heart Association"},{"issue":"9","key":"1526_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","volume":"18","author":"JD Duarte","year":"2021","unstructured":"Duarte JD, Cavallari LH. Pharmacogenetics to guide cardiovascular drug therapy. Nat Rev Cardiol. 2021;18(9):649\u201365. https:\/\/doi.org\/10.1038\/s41569-021-00549-w.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1526_CR52","doi-asserted-by":"publisher","first-page":"e006155","DOI":"10.1161\/CIRCHEARTFAILURE.119.006155","volume":"13","author":"HD D\u00fcngen","year":"2020","unstructured":"D\u00fcngen HD, Dordevic A, Felix SB, Pieske B, Voors AA, McMurray JJV, et al. \u03b21-adrenoreceptor autoantibodies in heart failure. Circulation: Heart Fail. 2020;13(1):e006155. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006155.","journal-title":"Circulation: Heart Fail"},{"issue":"9","key":"1526_CR53","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1097\/CCM.0000000000005503","volume":"50","author":"M Durand","year":"2022","unstructured":"Durand M, Hagimont E, Louis H, Asfar P, Frippiat JP, Singer M, et al. The \u03b21-adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory T-cell inhibitory function. Crit Care Med. 2022;50(9):e707\u201318. https:\/\/doi.org\/10.1097\/CCM.0000000000005503.","journal-title":"Crit Care Med"},{"issue":"2","key":"1526_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-5728(95)00080-L","volume":"61","author":"IJ Elenkov","year":"1995","unstructured":"Elenkov IJ, Hask G, Kov KJ, Vizi S. Modulation of lipopolysaccharide-induced tumor necrosis factor-a production by selective cy- and P-adrenergic drugs in mice. J Neuroimmunol. 1995;61(2):123\u201331.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1526_CR55","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","volume":"52","author":"IJ Elenkov","year":"2000","unstructured":"Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve\u2014an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev. 2000;52(4):595\u2013638. https:\/\/doi.org\/10.1016\/S0031-6997(24)01470-4.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"1526_CR56","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/eji.201646395","volume":"46","author":"LD Estrada","year":"2016","unstructured":"Estrada LD, A\u011fa\u00e7 D, Farrar JD. Sympathetic neural signaling via the \u03b22-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8\u2009+\u2009T-cell effector function. Eur J Immunol. 2016;46(8):1948\u201358. https:\/\/doi.org\/10.1002\/eji.201646395.","journal-title":"Eur J Immunol"},{"issue":"8","key":"1526_CR57","doi-asserted-by":"publisher","first-page":"e0272017","DOI":"10.1371\/journal.pone.0272017","volume":"17","author":"LD Estrada","year":"2022","unstructured":"Estrada LD, \u00c7obano\u011flu DA, Wise A, Maples RW, \u00c7obano\u011flu MC, Farrar JD. Adrenergic signaling controls early transcriptional programs during CD8\u2009+\u2009T cell responses to viral infection. PLoS ONE. 2022;17(8):e0272017. https:\/\/doi.org\/10.1371\/journal.pone.0272017.","journal-title":"PLoS ONE"},{"key":"1526_CR58","doi-asserted-by":"publisher","unstructured":"Fan H, Liang X, Tang Y. Neuroscience in peripheral cancers: Tumors hijacking nerves and neuroimmune crosstalk. MedComm (2020). 2024;5(11):e784. https:\/\/doi.org\/10.1002\/mco2 784 PubMed PMID: 39492832; PubMed Central PMCID: PMC11527832.","DOI":"10.1002\/mco2"},{"issue":"16","key":"1526_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms241612837","volume":"24","author":"MA Farooq","year":"2023","unstructured":"Farooq MA, Ajmal I, Hui X, Chen Y, Ren Y, Jiang W. \u03b22-adrenergic receptor mediated inhibition of T cell function and its implications for CAR-T cell therapy. Int J Mol Sci. 2023;24(16):16. https:\/\/doi.org\/10.3390\/ijms241612837.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1526_CR60","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4049\/jimmunol.135.2.755","volume":"135","author":"DL Felten","year":"1985","unstructured":"Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135(2):755\u201365. https:\/\/doi.org\/10.4049\/jimmunol.135.2.755.","journal-title":"J Immunol"},{"issue":"9","key":"1526_CR62","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fj\u00e6stad","year":"2022","unstructured":"Fj\u00e6stad KY, R\u00f8mer AMA, Goitea V, Johansen AZ, Thorseth ML, Carretta M, et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene. 2022;41(9):1364\u201375. https:\/\/doi.org\/10.1038\/s41388-021-02170-0.","journal-title":"Oncogene"},{"issue":"1","key":"1526_CR61","doi-asserted-by":"publisher","first-page":"10063","DOI":"10.1038\/s41467-025-65048-9","volume":"16","author":"KY Fj\u00e6stad","year":"2025","unstructured":"Fj\u00e6stad KY, Johansen AZ, Linder H, Baker KJ, Schattefor M, Czajkowski NK, et al. \u03b2-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells. Nat Commun. 2025;16(1):10063. https:\/\/doi.org\/10.1038\/s41467-025-65048-9.","journal-title":"Nat Commun"},{"issue":"5","key":"1526_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.psyneuen.2009.10.005","volume":"35","author":"E Freier","year":"2010","unstructured":"Freier E, Weber CS, Nowottne U, Horn C, Bartels K, Meyer S, et al. Decrease of CD4\u2009+\u2009FOXP3+ T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinology. 2010;35(5):663\u201373. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.10.005.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1526_CR64","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4110\/in.2023.23.e5","volume":"23","author":"MJ Friedman","year":"2023","unstructured":"Friedman MJ, Lee H, Lee JY, Oh S. Transcriptional and epigenetic regulation of context-dependent plasticity in T-helper lineages. Immune Netw. 2023;23(1):e5. https:\/\/doi.org\/10.4110\/in.2023.23.e5.","journal-title":"Immune Netw"},{"issue":"1","key":"1526_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/HEP.0000000000000014","volume":"78","author":"S Fu","year":"2023","unstructured":"Fu S, Liu M, Zhu C, Zhang H, Zhao C, Xie Y, et al. Regulatory mucosa-associated invariant T cells controlled by \u03b21 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 2023;78(1):72. https:\/\/doi.org\/10.1097\/HEP.0000000000000014.","journal-title":"Hepatology"},{"key":"1526_CR66","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","volume":"151","author":"C Fumagalli","year":"2020","unstructured":"Fumagalli C, Maurizi N, Marchionni N, Fornasari D. \u03b2-blockers: Their new life from hypertension to cancer and migraine. Pharmacol Res. 2020;151:104587. https:\/\/doi.org\/10.1016\/j.phrs.2019.104587.","journal-title":"Pharmacol Res"},{"issue":"9","key":"1526_CR67","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1007\/s12035-024-03991-2","volume":"61","author":"CR Gafurova","year":"2024","unstructured":"Gafurova CR, Tsentsevitsky AN, Fedorov NS, Khaziev AN, Malomouzh AI, Petrov AM. \u03b22-adrenergic regulation of the neuromuscular transmission and its lipid-dependent switch. Mol Neurobiol. 2024;61(9):6805\u201321. https:\/\/doi.org\/10.1007\/s12035-024-03991-2.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1526_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-20-2381","volume":"27","author":"S Gandhi","year":"2021","unstructured":"Gandhi S, Pandey MR, Attwood K, Ji W, Witkiewicz AK, Knudsen ES, et al. Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: Safety, tolerability, and preliminary evidence of antitumor activity. Clin Cancer Res. 2021;27(1):87\u201395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2381.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1526_CR69","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41416-022-02132-7","volume":"128","author":"Q Geng","year":"2023","unstructured":"Geng Q, Li L, Shen Z, Zheng Y, Wang L, Xue R, et al. Norepinephrine inhibits CD8\u2009+\u2009T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma. Br J Cancer. 2023;128(7):1223\u201335. https:\/\/doi.org\/10.1038\/s41416-022-02132-7.","journal-title":"Br J Cancer"},{"key":"1526_CR70","doi-asserted-by":"publisher","unstructured":"Ghareghani M, Reiter RJ, Zibara K, Farhadi N. Latitude, vitamin D, melatonin, and gut microbiota act in concert to initiate multiple sclerosis: A new mechanistic pathway. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.02484.","DOI":"10.3389\/fimmu.2018.02484"},{"issue":"2","key":"1526_CR71","doi-asserted-by":"publisher","first-page":"e87840","DOI":"10.1371\/journal.pone.0087840","volume":"9","author":"N Ghazanfari","year":"2014","unstructured":"Ghazanfari N, Morsch M, Tse N, Reddel SW, Phillips WD. Effects of the \u00df2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. PLoS ONE. 2014;9(2):e87840. https:\/\/doi.org\/10.1371\/journal.pone.0087840.","journal-title":"PLoS ONE"},{"issue":"1","key":"1526_CR72","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","volume":"170","author":"HE Ghoneim","year":"2017","unstructured":"Ghoneim HE, Fan Y, Moustaki A, Abdelsamed HA, Dash P, Dogra P, et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell. 2017;170(1):142\u2013e15719. https:\/\/doi.org\/10.1016\/j.cell.2017.06.007. PubMed PMID: 28648661.","journal-title":"Cell"},{"issue":"7982","key":"1526_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, Zhao S, Roginsky J, Maltez VI, Guiza J, Avina-Ochoa N, et al. The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature. 2023;622(7982):383\u201392. https:\/\/doi.org\/10.1038\/s41586-023-06568-6.","journal-title":"Nature"},{"issue":"10","key":"1526_CR74","doi-asserted-by":"publisher","first-page":"107947","DOI":"10.1016\/j.isci.2023.107947","volume":"26","author":"MB Gonzatti","year":"2023","unstructured":"Gonzatti MB, Freire BM, Antunes MM, De Menezes GB, Talbot J, Peron JPS, et al. Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury. iScience. 2023;26(10):107947. https:\/\/doi.org\/10.1016\/j.isci.2023.107947.","journal-title":"iScience"},{"issue":"1","key":"1526_CR75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00520-019-04805-1","volume":"28","author":"H G\u00f6tze","year":"2020","unstructured":"G\u00f6tze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer. 2020;28(1):211\u201320. https:\/\/doi.org\/10.1007\/s00520-019-04805-1.","journal-title":"Support Care Cancer"},{"issue":"13","key":"1526_CR76","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1073\/pnas.0808851106","volume":"106","author":"KM Grebe","year":"2009","unstructured":"Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW. Sympathetic nervous system control of anti-influenza CD8\u2009+\u2009T cell responses. Proc Natl Acad Sci USA. 2009;106(13):5300\u20135. https:\/\/doi.org\/10.1073\/pnas.0808851106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1526_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.phrs.2018.07.019","volume":"135","author":"N Griffin","year":"2018","unstructured":"Griffin N, Faulkner S, Jobling P, Hondermarck H. Targeting neurotrophin signaling in cancer: The renaissance. Pharmacol Res. 2018;135:12\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.019.","journal-title":"Pharmacol Res"},{"key":"1526_CR78","doi-asserted-by":"publisher","unstructured":"Grover P, Goel PN, Greene MI. Regulatory T cells: Regulation of identity and function. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.750542.","DOI":"10.3389\/fimmu.2021.750542"},{"issue":"27","key":"1526_CR79","doi-asserted-by":"publisher","first-page":"20726","DOI":"10.1074\/jbc.M000152200","volume":"275","author":"C Gu","year":"2000","unstructured":"Gu C, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. Apoptotic signaling through the \u03b2-adrenergic receptor: A new Gs effector pathway. J Biol Chem. 2000;275(27):20726\u201333. https:\/\/doi.org\/10.1074\/jbc.M000152200.","journal-title":"J Biol Chem"},{"issue":"4","key":"1526_CR80","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/eji.201243005","volume":"43","author":"MG Guereschi","year":"2013","unstructured":"Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, et al. Beta2-adrenergic receptor signaling in CD4\u2009+\u2009Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol. 2013;43(4):1001\u201312. https:\/\/doi.org\/10.1002\/eji.201243005.","journal-title":"Eur J Immunol"},{"key":"1526_CR81","doi-asserted-by":"publisher","unstructured":"Hajiaghayi M, Gholizadeh F, Han E, Little SR, Rahbari N, Ardila I, et al. The \u03b22-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-\u03baB-dependent manner. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1446424.","DOI":"10.3389\/fimmu.2024.1446424"},{"issue":"5","key":"1526_CR82","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam A, Prasad V. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open. 2019;2(5):e192535. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2535.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1526_CR83","doi-asserted-by":"publisher","first-page":"2200046","DOI":"10.1002\/adbi.202200046","volume":"6","author":"S Hernandez","year":"2022","unstructured":"Hernandez S, Serrano AG, Solis Soto LM. The role of nerve fibers in the tumor immune microenvironment of solid tumors. Adv Biology. 2022;6(9):2200046. https:\/\/doi.org\/10.1002\/adbi.202200046.","journal-title":"Adv Biology"},{"issue":"8","key":"1526_CR84","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller JG, Cole SW, Crone EM, Byrne DJ, Shackleford DM, Pang JMB, et al. Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: A phase II randomized trial. Clin Cancer Res. 2020;26(8):1803\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2641.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1526_CR85","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCRESAHA.112.272682","volume":"111","author":"HP Holthoff","year":"2012","unstructured":"Holthoff HP, Zeibig S, Jahns-Boivin V, Bauer J, Lohse MJ, K\u00e4\u00e4b S, et al. Detection of anti\u2013\u03b21-AR autoantibodies in heart failure by a cell-based competition ELISA. Circul Res. 2012;111(6):675\u201384. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.272682.","journal-title":"Circul Res"},{"issue":"6","key":"1526_CR86","doi-asserted-by":"publisher","first-page":"188828","DOI":"10.1016\/j.bbcan.2022.188828","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu J, Chen W, Shen L, Chen Z, Huang J. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2022;1877(6):188828. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188828.","journal-title":"Biochim et Biophys Acta (BBA) - Reviews Cancer"},{"issue":"8","key":"1526_CR87","first-page":"3417","volume":"13","author":"YH Hung","year":"2023","unstructured":"Hung YH, Hou YC, Hsu SH, Wang LY, Tsai YL, Shan YS, et al. Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination. Am J Cancer Res. 2023;13(8):3417\u201332. PubMed PMID: 37693128; PubMed Central PMCID: PMC10492129.","journal-title":"Am J Cancer Res"},{"key":"1526_CR88","doi-asserted-by":"publisher","unstructured":"Hylander BL, Eng JWL, Repasky EA. The impact of housing temperature-induced chronic stress on preclinical mouse tumor models and therapeutic responses: An important role for the nervous system. In: Kalinski P, editor. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy [Internet]. Cham: Springer International Publishing; 2017 [cited 2026 May 12]. pp. 173\u201389. Available from: https:\/\/doi.org\/10.1007\/978-3-319-67577-0_12.","DOI":"10.1007\/978-3-319-67577-0_12"},{"issue":"3","key":"1526_CR89","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/ani12030371","volume":"12","author":"BL Hylander","year":"2022","unstructured":"Hylander BL, Repasky EA, Sexton S. Using mice to model human disease: Understanding the roles of baseline housing-induced and experimentally imposed stresses in animal welfare and experimental reproducibility. Animals. 2022;12(3):371. https:\/\/doi.org\/10.3390\/ani12030371.","journal-title":"Animals"},{"issue":"1","key":"1526_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tcm.2005.11.002","volume":"16","author":"R Jahns","year":"2006","unstructured":"Jahns R, Boivin V, Lohse MJ. \u03b21-adrenergic receptor function, autoimmunity, and pathogenesis of dilated Cardiomyopathy. Trends Cardiovasc Med. 2006;16(1):20\u20134. https:\/\/doi.org\/10.1016\/j.tcm.2005.11.002.","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"1526_CR91","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","volume":"39","author":"SH Jiang","year":"2020","unstructured":"Jiang SH, Hu LP, Wang X, Li J, Zhang ZG, Neurotransmitters. Emerging targets in cancer. Oncogene. 2020;39(3):503\u201315. https:\/\/doi.org\/10.1038\/s41388-019-1006-0.","journal-title":"Oncogene"},{"key":"1526_CR92","doi-asserted-by":"publisher","unstructured":"Jin X, Liu Z, Yang D, Yin K, Chang X. Recent progress and future perspectives of immunotherapy in advanced gastric cancer. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.948647.","DOI":"10.3389\/fimmu.2022.948647"},{"key":"1526_CR93","doi-asserted-by":"publisher","unstructured":"Jing D, Xiong L, Zhang R, Fang H, Chen L. Esmolol improves sepsis outcomes through cardiovascular and immune modulation. Front Pharmacol. 2025;16. https:\/\/doi.org\/10.3389\/fphar.2025.1498227.","DOI":"10.3389\/fphar.2025.1498227"},{"key":"1526_CR94","doi-asserted-by":"publisher","unstructured":"Kavelaars A. Regulated expression of \u03b1-1 adrenergic receptors in the immune system. Brain, Behavior, and Immunity. 2002;16(6):799\u2013807. https:\/\/doi.org\/10.1016\/S0889-1591(02)00033-8","DOI":"10.1016\/S0889-1591(02)00033-8"},{"issue":"6","key":"1526_CR95","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41440-023-01265-3","volume":"46","author":"F Ke","year":"2023","unstructured":"Ke F, Kuang W, Hu X, Li C, Ma W, Shi D, et al. A novel vaccine targeting \u03b21-adrenergic receptor. Hypertens Res. 2023;46(6):1582\u201395. https:\/\/doi.org\/10.1038\/s41440-023-01265-3.","journal-title":"Hypertens Res"},{"issue":"1\u20132","key":"1526_CR96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jns.2014.06.053","volume":"344","author":"DM Keller","year":"2014","unstructured":"Keller DM, Fadel PJ, Harnsberger MA, Remington GM, Frohman EM, Davis SL. Reduced spontaneous sympathetic nerve activity in multiple sclerosis patients. J Neurol Sci. 2014;344(1\u20132):210\u20134. https:\/\/doi.org\/10.1016\/j.jns.2014.06.053.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1526_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-020-20302-0","volume":"12","author":"YM Khaw","year":"2021","unstructured":"Khaw YM, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-\u03b2 resistance and neurodegeneration in a multiple sclerosis model via downregulated \u03b21-adrenergic signaling. Nat Commun. 2021;12(1):105. https:\/\/doi.org\/10.1038\/s41467-020-20302-0.","journal-title":"Nat Commun"},{"issue":"7","key":"1526_CR98","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbi.2010.05.003","volume":"24","author":"BJ Kim","year":"2010","unstructured":"Kim BJ, Jones HP, Brain. Behav Immun. 2010;24(7):1126\u201336. https:\/\/doi.org\/10.1016\/j.bbi.2010.05.003.","journal-title":"Behav Immun"},{"issue":"6","key":"1526_CR99","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1189\/jlb.1105625","volume":"79","author":"NW Kin","year":"2006","unstructured":"Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006;79(6):1093\u2013104. https:\/\/doi.org\/10.1189\/jlb.1105625.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1526_CR100","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-neuro-111020-105359","volume":"45","author":"RGJ Klein Wolterink","year":"2022","unstructured":"Klein Wolterink RGJ, Wu GS, Chiu IM, Veiga-Fernandes H. Neuroimmune interactions in peripheral organs. Annu Rev Neurosci. 2022;45(1):339\u201360. https:\/\/doi.org\/10.1146\/annurev-neuro-111020-105359.","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"1526_CR101","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm AP, Sanders VM. Norepinephrine and \u03b22-adrenergic receptor stimulation regulate CD4\u2009+\u2009T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53(4):487\u2013525. https:\/\/doi.org\/10.1016\/S0031-6997(24)01510-2.","journal-title":"Pharmacol Rev"},{"issue":"50","key":"1526_CR102","doi-asserted-by":"publisher","first-page":"20176","DOI":"10.1073\/pnas.1304291110","volume":"110","author":"KM Kokolus","year":"2013","unstructured":"Kokolus KM, Capitano ML, Lee CT, Eng JWL, Waight JD, Hylander BL, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci. 2013;110(50):20176\u201381. https:\/\/doi.org\/10.1073\/pnas.1304291110.","journal-title":"Proc Natl Acad Sci"},{"key":"1526_CR103","doi-asserted-by":"publisher","unstructured":"Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 2016;113(29):8284\u20139. https:\/\/doi.org\/10.1073\/pnas.1605635113","DOI":"10.1073\/pnas.1605635113"},{"issue":"6","key":"1526_CR104","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s12192-020-01136-7","volume":"25","author":"HE Kunz","year":"2020","unstructured":"Kunz HE, Agha NH, Hussain M, LaVoy EC, Smith KA, Mylabathula P, et al. The effects of \u03b21 and \u03b21\u2009+\u20092 adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: Implications for cellular therapy and the anti-viral immune effects of exercise. Cell Stress Chaperones. 2020;25(6):993\u20131012. https:\/\/doi.org\/10.1007\/s12192-020-01136-7.","journal-title":"Cell Stress Chaperones"},{"key":"1526_CR105","doi-asserted-by":"publisher","unstructured":"Kyritsi K, Pacholczyk R, Douglass E, Yu M, Fang H, Zhou G, et al. \u03b2-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy. J Immunother Cancer. 2025;13(4). https:\/\/doi.org\/10.1136\/jitc-2024-011322. PubMed PMID:.","DOI":"10.1136\/jitc-2024-011322"},{"key":"1526_CR106","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbi.2024.11.013","volume":"123","author":"TH Lauten","year":"2025","unstructured":"Lauten TH, Elkhatib SK, Natour T, Reed EC, Jojo CN, Case AJ, Brain. Behav Immun. 2025a;123:1061\u201370. https:\/\/doi.org\/10.1016\/j.bbi.2024.11.013.","journal-title":"Behav Immun"},{"key":"1526_CR107","doi-asserted-by":"publisher","first-page":"578705","DOI":"10.1016\/j.jneuroim.2025.578705","volume":"407","author":"TH Lauten","year":"2025","unstructured":"Lauten TH, Reed EC, Natour T, Pitts LJ, Jojo CN, Griffin BL, et al. Beta adrenergic signaling as a therapeutic target for autoimmunity. J Neuroimmunol. 2025b;407:578705. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578705.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1526_CR29","doi-asserted-by":"publisher","first-page":"2284486","DOI":"10.1080\/2162402","volume":"12","author":"K Le Carnet","year":"2023","unstructured":"Le Carnet K, Kepp O, Kroemer G, Bezu L. Trial watch: Beta-blockers in cancer therapy. Oncoimmunology. 2023;12(1):2284486. https:\/\/doi.org\/10.1080\/2162402. X.2023.2284486 PubMed PMID: 38126031; PubMed Central PMCID: PMC10732641.","journal-title":"Oncoimmunology"},{"issue":"4","key":"1526_CR109","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5483\/BMBRep.2024-0019","volume":"57","author":"HP Lee","year":"2024","unstructured":"Lee HP. The contribution of the nervous system in the cancer progression. BMB Rep. 2024;57(4):167\u201375. https:\/\/doi.org\/10.5483\/BMBRep.2024-0019.","journal-title":"BMB Rep"},{"issue":"3","key":"1526_CR108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7570\/jomes25050","volume":"34","author":"CH Lee","year":"2025","unstructured":"Lee CH. Neuro-immune interactions in metabolic regulation: Brain and adipose tissue crosstalk. J Obes Metabolic Syndrome. 2025;34(3):182\u201395. https:\/\/doi.org\/10.7570\/jomes25050.","journal-title":"J Obes Metabolic Syndrome"},{"key":"1526_CR110","doi-asserted-by":"publisher","unstructured":"Lei Y, Liao F, Tian Y, Wang Y, Xia F, Wang J. Investigating the crosstalk between chronic stress and immune cells: Implications for enhanced cancer therapy. Front Neurosci. 2023;17. https:\/\/doi.org\/10.3389\/fnins.2023.1321176.","DOI":"10.3389\/fnins.2023.1321176"},{"key":"1526_CR111","doi-asserted-by":"publisher","unstructured":"Lepore MT, Bruzzaniti S, La Rocca C, Fusco C, Carbone F, Mottola M, et al. Deciphering the role of protein kinase a in the control of FoxP3 expression in regulatory T cells in health and autoimmunity. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-68098-z.","DOI":"10.1038\/s41598-024-68098-z"},{"key":"1526_CR112","doi-asserted-by":"publisher","first-page":"0679","DOI":"10.34133\/research.0679","volume":"8","author":"M Li","year":"2025","unstructured":"Li M, Sun X, Zeng L, Sun A, Ge J. Metabolic homeostasis of immune cells modulates cardiovascular diseases. Research. 2025a;8:0679. https:\/\/doi.org\/10.34133\/research.0679.","journal-title":"Research"},{"key":"1526_CR113","doi-asserted-by":"publisher","unstructured":"Li Q, Xu S, Ren Y, Zhang C, Li K, Liu Y. Single-cell RNA sequencing reveals adrb1 as a sympathetic nerve-regulated immune checkpoint driving T cell exhaustion and impacting immunotherapy in esophageal squamous cell carcinoma. Front Immunol. 2025b;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1520766.","DOI":"10.3389\/fimmu.2025.1520766"},{"key":"1526_CR114","doi-asserted-by":"publisher","first-page":"175718","DOI":"10.1016\/j.ejphar.2023.175718","volume":"949","author":"Y Lin","year":"2023","unstructured":"Lin Y, Liu Y, Gao Z, Jing D, Bi R, Cui X, et al. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer. Eur J Pharmacol. 2023;949:175718. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175718.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"1526_CR117","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0735-1097(02)01865-X","volume":"39","author":"HR Liu","year":"2002","unstructured":"Liu HR, Zhao RR, Jiao XY, Wang YY, Fu M. Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta1-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol. 2002;39(11):1866\u201373. https:\/\/doi.org\/10.1016\/S0735-1097(02)01865-X.","journal-title":"J Am Coll Cardiol"},{"key":"1526_CR118","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.12659\/MSM.906184","volume":"24","author":"Y Liu","year":"2018","unstructured":"Liu Y, Rui XX, Shi H, Qiu YH, Peng YP. Norepinephrine inhibits Th17 cells via \u03b22-adrenergic receptor (\u03b22-AR) signaling in a mouse model of rheumatoid arthritis. Med Sci Monit. 2018;24:1196\u2013204. https:\/\/doi.org\/10.12659\/MSM.906184.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1526_CR115","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40779-022-00422-y","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: Mechanisms, diagnosis and current treatment options. Military Med Res. 2022a;9(1):56. https:\/\/doi.org\/10.1186\/s40779-022-00422-y.","journal-title":"Military Med Res"},{"key":"1526_CR119","doi-asserted-by":"publisher","unstructured":"Liu Y, Tian S, Ning B, Huang T, Li Y, Wei Y. Stress and cancer: The mechanisms of immune dysregulation and management. Front Immunol. 2022b;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1032294.","DOI":"10.3389\/fimmu.2022.1032294"},{"key":"1526_CR116","doi-asserted-by":"publisher","unstructured":"Liu FJ, Wu J, Gong LJ, Yang HS, Chen H. Non-invasive vagus nerve stimulation in anti-inflammatory therapy: Mechanistic insights and future perspectives. Front Neurosci. 2024;18. https:\/\/doi.org\/10.3389\/fnins.2024.1490300.","DOI":"10.3389\/fnins.2024.1490300"},{"issue":"6","key":"1526_CR120","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-022-01891-7","volume":"127","author":"LL L\u00f8fling","year":"2022","unstructured":"L\u00f8fling LL, St\u00f8er NC, Sloan EK, Chang A, Gandini S, Ursin G, et al. \u03b2-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. Br J Cancer. 2022;127(6):1086\u201396. https:\/\/doi.org\/10.1038\/s41416-022-01891-7.","journal-title":"Br J Cancer"},{"issue":"1","key":"1526_CR121","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12974-020-02021-x","volume":"17","author":"J Loos","year":"2020","unstructured":"Loos J, Schmaul S, Noll TM, Paterka M, Schillner M, L\u00f6ffel JT, et al. Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy. J Neuroinflamm. 2020;17(1):357. https:\/\/doi.org\/10.1186\/s12974-020-02021-x.","journal-title":"J Neuroinflamm"},{"issue":"6","key":"1526_CR122","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","volume":"24","author":"JS Lorente","year":"2025","unstructured":"Lorente JS, Sokolov AV, Ferguson G, Schi\u00f6th HB, Hauser AS, Gloriam DE. GPCR drug discovery: New agents, targets and indications. Nat Rev Drug Discov. 2025;24(6):458\u201379. https:\/\/doi.org\/10.1038\/s41573-025-01139-y.","journal-title":"Nat Rev Drug Discov"},{"key":"1526_CR123","doi-asserted-by":"publisher","unstructured":"Lorton D. Targeting \u03b1- and \u03b2-adrenergic receptors differentially shifts Th1, Th2, and inflammatory cytokine profiles in immune organs to attenuate adjuvant arthritis. Front Immunol. 2014;5. https:\/\/doi.org\/10.3389\/fimmu.2014.00346.","DOI":"10.3389\/fimmu.2014.00346"},{"issue":"3","key":"1526_CR125","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms16035635","volume":"16","author":"D Lorton","year":"2015","unstructured":"Lorton D, Bellinger DL. Molecular mechanisms underlying \u03b2-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells. Int J Mol Sci. 2015;16(3):3. https:\/\/doi.org\/10.3390\/ijms16035635.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1526_CR124","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0165-5728(95)00150-6","volume":"64","author":"D Lorton","year":"1996","unstructured":"Lorton D, Bellinger D, Duclos M, Felten SY, Felten DL. Application of 6-hydroxydopamine into the fatpads surrounding the draining lymph nodes exacerbates adjuvant-induced arthritis. J Neuroimmunol. 1996;64(2):103\u201313. https:\/\/doi.org\/10.1016\/0165-5728(95)00150-6.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"1526_CR126","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/glia.23993","volume":"69","author":"TA Lucas","year":"2021","unstructured":"Lucas TA, Zhu L, Buckwalter MS. Spleen glia are a transcriptionally unique glial subtype interposed between immune cells and sympathetic axons. Glia. 2021;69(7):1799\u2013815. https:\/\/doi.org\/10.1002\/glia.23993.","journal-title":"Glia"},{"issue":"5","key":"1526_CR127","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/SHK.0000000000002104","volume":"59","author":"Y Ma","year":"2023","unstructured":"Ma Y, Cheng Z, Zheng Y, Wang W, He S, Zhou X, et al. Low dose of esmolol attenuates sepsis-induced immunosuppression via modulating T-lymphocyte apoptosis and differentiation. Shock. 2023;59(5):771. https:\/\/doi.org\/10.1097\/SHK.0000000000002104.","journal-title":"Shock"},{"issue":"5","key":"1526_CR128","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/STROKEAHA.116.015936","volume":"48","author":"O Magvanjav","year":"2017","unstructured":"Magvanjav O, McDonough CW, Gong Y, McClure LA, Talbert RL, Horenstein RB, et al. Pharmacogenetic associations of \u03b21-adrenergic receptor polymorphisms with cardiovascular outcomes in the SPS3 trial (secondary prevention of small subcortical strokes). Stroke. 2017;48(5):1337\u201343. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015936.","journal-title":"Stroke"},{"key":"1526_CR129","doi-asserted-by":"publisher","unstructured":"Maine CJ, Teijaro JR, Marquardt K, Sherman LA. PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection. Proc Natl Acad Sci USA. 2016;113(46). https:\/\/doi.org\/10.1073\/pnas.1603738113.","DOI":"10.1073\/pnas.1603738113"},{"issue":"1","key":"1526_CR130","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Primers. 2023;9(1):27. https:\/\/doi.org\/10.1038\/s41572-023-00438-1.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1526_CR131","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1136\/ard.2007.083782","volume":"67","author":"O Malysheva","year":"2008","unstructured":"Malysheva O, Pierer M, Wagner U, Wahle M, Wagner U, Baerwald CG. Association between \u03b22 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope. Ann Rheum Dis. 2008;67(12):1759\u201364. https:\/\/doi.org\/10.1136\/ard.2007.083782.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1526_CR132","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/cvr\/cvad042","volume":"119","author":"G Markousis-Mavrogenis","year":"2023","unstructured":"Markousis-Mavrogenis G, Minich WB, Al-Mubarak AA, Anker SD, Cleland JGF, Dickstein K, et al. Clinical and prognostic associations of autoantibodies recognizing adrenergic\/muscarinic receptors in patients with heart failure. Cardiovasc Res. 2023;119(8):1690\u2013705. https:\/\/doi.org\/10.1093\/cvr\/cvad042.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1526_CR133","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00421-022-05126-8","volume":"123","author":"A Markov","year":"2023","unstructured":"Markov A, Bussweiler J, Helm N, Arntz F, Steidten T, Krohm L, et al. Acute effects of concurrent muscle power and sport-specific endurance exercises on markers of immunological stress response and measures of muscular fitness in highly trained youth male athletes. Eur J Appl Physiol. 2023;123(5):1015\u201326. https:\/\/doi.org\/10.1007\/s00421-022-05126-8.","journal-title":"Eur J Appl Physiol"},{"issue":"21","key":"1526_CR134","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.neuron.2022.10.017","volume":"110","author":"N Martinez-Sanchez","year":"2022","unstructured":"Martinez-Sanchez N, Sweeney O, Sidarta-Oliveira D, Caron A, Stanley SA, Domingos AI. The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity. Neuron. 2022;110(21):3597\u2013626. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.017. PubMed PMID: 36327900.","journal-title":"Neuron"},{"issue":"1","key":"1526_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCRESAHA.124.324999","volume":"136","author":"E Martini","year":"2025","unstructured":"Martini E, Cremonesi M, Felicetta A, Serio S, Puccio S, Pelamatti E, et al. Autoimmune-like mechanism in heart failure enables preventive vaccine therapy. Circul Res. 2025;136(1):4\u201325. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.324999.","journal-title":"Circul Res"},{"issue":"5","key":"1526_CR136","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri3442","volume":"13","author":"D Masopust","year":"2013","unstructured":"Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol. 2013;13(5):309\u201320. https:\/\/doi.org\/10.1038\/nri3442.","journal-title":"Nat Rev Immunol"},{"key":"1526_CR137","doi-asserted-by":"publisher","unstructured":"Massalee R, Cao X. Repurposing beta-blockers for combinatory cancer treatment: Effects on conventional and immune therapies. Front Pharmacol. 2024;14. https:\/\/doi.org\/10.3389\/fphar.2023.1325050.","DOI":"10.3389\/fphar.2023.1325050"},{"issue":"3","key":"1526_CR138","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbi.2010.10.019","volume":"25","author":"JW McAlees","year":"2011","unstructured":"McAlees JW, Smith LT, Erbe RS, Jarjoura D, Ponzio NM, Sanders VM, Brain. Behav Immun. 2011;25(3):408\u201315. https:\/\/doi.org\/10.1016\/j.bbi.2010.10.019.","journal-title":"Behav Immun"},{"issue":"2","key":"1526_CR139","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ijms23020668","volume":"23","author":"M Melnikov","year":"2022","unstructured":"Melnikov M, Rogovskii V, Sviridova A, Lopatina A, Pashenkov M, Boyko A. The dual role of the \u03b22-adrenoreceptor in the modulation of IL-17 and IFN-\u03b3 production by T cells in multiple sclerosis. Int J Mol Sci. 2022;23(2):2. https:\/\/doi.org\/10.3390\/ijms23020668.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1526_CR140","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1096\/fj.99-1082com","volume":"14","author":"LE Miller","year":"2000","unstructured":"Miller LE, J\u00fcsten H, peter, Schc\u00f6lmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 2000;14(13):2097\u2013107. https:\/\/doi.org\/10.1096\/fj.99-1082com.","journal-title":"FASEB J"},{"issue":"4","key":"1526_CR141","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/he.2000.5850","volume":"31","author":"M Minagawa","year":"2000","unstructured":"Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology. 2000;31(4):907\u201315. https:\/\/doi.org\/10.1053\/he.2000.5850.","journal-title":"Hepatology"},{"issue":"12","key":"1526_CR142","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, et al. \u03b22 adrenergic receptor\u2013mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129(12):5537\u201352. doi:10.1172\/JCI129502 PubMed PMID: 0.","journal-title":"J Clin Invest"},{"key":"1526_CR143","doi-asserted-by":"publisher","unstructured":"Mohammadpour H, Sarow JL, MacDonald CR, Chen GL, Qiu J, Sharma UC, et al. \u03b22-adrenergic receptor activation on donor cells ameliorates acute GvHD. JCI Insight. 2021;5(12). https:\/\/doi.org\/10.1172\/jci.insight.137788 . PubMed PMID: 0.","DOI":"10.1172\/jci.insight.137788"},{"issue":"4","key":"1526_CR144","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.18632\/oncotarget.14119","volume":"8","author":"A Montoya","year":"2016","unstructured":"Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, et al. Use of non-selective \u03b2-blockers is associated with decreased tumor proliferative indices in early stage breast cancer. Oncotarget. 2016;8(4):6446\u201360. https:\/\/doi.org\/10.18632\/oncotarget.14119.","journal-title":"Oncotarget"},{"issue":"3","key":"1526_CR145","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrrheum.2018.2","volume":"14","author":"EF Morand","year":"2018","unstructured":"Morand EF. Stress and the onset of SLE. Nat Rev Rheumatol. 2018;14(3):127\u20138. https:\/\/doi.org\/10.1038\/nrrheum.2018.2.","journal-title":"Nat Rev Rheumatol"},{"issue":"6379","key":"1526_CR146","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.aan4829","volume":"359","author":"S Moriyama","year":"2018","unstructured":"Moriyama S, Brestoff JR, Flamar AL, Moeller JB, Klose CSN, Rankin LC, et al. \u03b22-adrenergic receptor\u2013mediated negative regulation of group 2 innate lymphoid cell responses. Science. 2018;359(6379):1056\u201361. https:\/\/doi.org\/10.1126\/science.aan4829.","journal-title":"Science"},{"issue":"10","key":"1526_CR147","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","volume":"19","author":"T Moser","year":"2020","unstructured":"Moser T, Akg\u00fcn K, Proschmann U, Sellner J, Ziemssen T. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun rev. 2020;19(10):102647. https:\/\/doi.org\/10.1016\/j.autrev.2020.102647.","journal-title":"Autoimmun rev"},{"issue":"21","key":"1526_CR148","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.3390\/ijms21217958","volume":"21","author":"B Mravec","year":"2020","unstructured":"Mravec B, Horvathova L, Hunakova L. Neurobiology of cancer: The role of \u03b2-adrenergic receptor signaling in various tumor environments. IJMS. 2020;21(21):7958. https:\/\/doi.org\/10.3390\/ijms21217958.","journal-title":"IJMS"},{"issue":"3","key":"1526_CR149","doi-asserted-by":"publisher","first-page":"e20211604","DOI":"10.1084\/jem.20211604","volume":"219","author":"SN Mueller","year":"2022","unstructured":"Mueller SN. Neural control of immune cell trafficking. J Exp Med. 2022;219(3):e20211604. https:\/\/doi.org\/10.1084\/jem.20211604.","journal-title":"J Exp Med"},{"issue":"13","key":"1526_CR150","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1084\/jem.20141132","volume":"211","author":"A Nakai","year":"2014","unstructured":"Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K. Control of lymphocyte egress from lymph nodes through \u03b22-adrenergic receptors. J Exp Med. 2014;211(13):2583\u201398. https:\/\/doi.org\/10.1084\/jem.20141132.","journal-title":"J Exp Med"},{"issue":"6","key":"1526_CR151","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.bbi.2007.03.008","volume":"21","author":"DM Nance","year":"2007","unstructured":"Nance DM, Sanders VM, Brain. Behav Immun. 2007;21(6):736\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2007.03.008.","journal-title":"Behav Immun"},{"issue":"20","key":"1526_CR152","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cells13201674","volume":"13","author":"W Parichatikanond","year":"2024","unstructured":"Parichatikanond W, Duangrat R, Kurose H, Mangmool S. Regulation of \u03b2-adrenergic receptors in the heart: A review on emerging therapeutic strategies for heart failure. Cells. 2024;13(20):20. https:\/\/doi.org\/10.3390\/cells13201674.","journal-title":"Cells"},{"issue":"1","key":"1526_CR153","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3803\/EnM.2016.31.1.142","volume":"31","author":"S Park","year":"2016","unstructured":"Park S, Kim TY, Sim S, Lim S, Kim M, Kwon H, et al. Thyrotoxic periodic paralysis and polymorphisms of the ADRB2, AR, and GABRA3 genes in men with graves disease. Endocrinol Metab (Seoul). 2016;31(1):142\u20136. 142 PubMed PMID: 26676335; PubMed Central PMCID: PMC4803550.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6316","key":"1526_CR154","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science. 2016;354(6316):1160\u20135. https:\/\/doi.org\/10.1126\/science.aaf2807.","journal-title":"Science"},{"issue":"8","key":"1526_CR155","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/eurjhf\/hfs082","volume":"14","author":"J Pei","year":"2012","unstructured":"Pei J, Li N, Chen J, Li X, Zhang Y, Wang Z, et al. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Eur J Heart Fail. 2012;14(8):887\u201394. https:\/\/doi.org\/10.1093\/eurjhf\/hfs082.","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"1526_CR156","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.3390\/ijms26167894","volume":"26","author":"MM Peklo","year":"2025","unstructured":"Peklo MM, Smolyakova EV, Lipatova LN, Kashirina NM, Skoblov YS, Skoblova NA, et al. A novel study of \u03b21- and \u03b22-adrenergic receptors present on PBMCs, T cells, monocytes, and NK cells by radioligand method: Quantitation and correlations. Int J Mol Sci. 2025;26(16):7894. https:\/\/doi.org\/10.3390\/ijms26167894.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1526_CR158","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8\u2009+\u2009T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209\u201323. https:\/\/doi.org\/10.1038\/s41577-021-00574-3.","journal-title":"Nat Rev Immunol"},{"issue":"7655","key":"1526_CR157","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature. 2017;545(7655):452\u20136. https:\/\/doi.org\/10.1038\/nature22367.","journal-title":"Nature"},{"issue":"2","key":"1526_CR163","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12026-019-09082-y","volume":"67","author":"I Pilipovi\u0107","year":"2019","unstructured":"Pilipovi\u0107 I, Vujnovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Petrovi\u0107 R, Kosec D, Nacka-Aleksi\u0107 M, et al. Noradrenaline modulates CD4\u2009+\u2009T cell priming in rat experimental autoimmune encephalomyelitis: A role for the \u03b11-adrenoceptor. Immunol Res. 2019;67(2):223\u201340. https:\/\/doi.org\/10.1007\/s12026-019-09082-y.","journal-title":"Immunol Res"},{"key":"1526_CR161","doi-asserted-by":"publisher","first-page":"104665","DOI":"10.1016\/j.nbd.2019.104665","volume":"134","author":"I Pilipovi\u0107","year":"2020","unstructured":"Pilipovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Priji\u0107 I, Jasni\u0107 N, Leposavi\u0107 G. Propranolol diminished severity of rat EAE by enhancing immunoregulatory\/protective properties of spinal cord microglia. Neurobiol Dis. 2020a;134:104665. https:\/\/doi.org\/10.1016\/j.nbd.2019.104665.","journal-title":"Neurobiol Dis"},{"key":"1526_CR162","doi-asserted-by":"publisher","unstructured":"Pilipovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Priji\u0107 I, Leposavi\u0107 G. Role of the end-point mediators of sympathoadrenal and sympathoneural stress axes in the pathogenesis of experimental autoimmune encephalomyelitis and multiple sclerosis. Front Endocrinol. 2020b;10. https:\/\/doi.org\/10.3389\/fendo.2019.00921.","DOI":"10.3389\/fendo.2019.00921"},{"key":"1526_CR159","doi-asserted-by":"publisher","first-page":"108358","DOI":"10.1016\/j.pharmthera.2023.108358","volume":"243","author":"I Pilipovi\u0107","year":"2023","unstructured":"Pilipovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Leposavi\u0107 G. Adrenoceptors as potential target for add-on immunomodulatory therapy in multiple sclerosis. Pharmacol Ther. 2023a;243:108358. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108358.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1526_CR160","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s10571-022-01246-z","volume":"43","author":"I Pilipovi\u0107","year":"2023","unstructured":"Pilipovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Priji\u0107 I, Jasni\u0107 N, Djordjevi\u0107 J, Leposavi\u0107 G. \u03b2-adrenoceptor blockade moderates neuroinflammation in male and female EAE rats and abrogates sexual dimorphisms in the major neuroinflammatory pathways by being more efficient in males. Cell Mol Neurobiol. 2023b;43(3):1237\u201365. https:\/\/doi.org\/10.1007\/s10571-022-01246-z.","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"1526_CR164","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","volume":"21","author":"GR Poe","year":"2020","unstructured":"Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. Locus coeruleus: A new look at the blue spot. Nat Rev Neurosci. 2020;21(11):644\u201359. https:\/\/doi.org\/10.1038\/s41583-020-0360-9.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"1526_CR165","doi-asserted-by":"publisher","first-page":"628","DOI":"10.18632\/oncotarget.197","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Z\u00e4nker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival. Oncotarget. 2010;1(7):628\u201338. https:\/\/doi.org\/10.18632\/oncotarget.197.","journal-title":"Oncotarget"},{"issue":"15","key":"1526_CR166","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/glia.20873","volume":"57","author":"L Qian","year":"2009","unstructured":"Qian L, Hu X, Zhang D, Snyder A, Wu HM, Li Y, et al. \u03b22 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent\/protein kinase A-independent pathway. Glia. 2009;57(15):1600\u20139. https:\/\/doi.org\/10.1002\/glia.20873.","journal-title":"Glia"},{"issue":"1","key":"1526_CR167","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","volume":"68","author":"G Qiao","year":"2019","unstructured":"Qiao G, Bucsek MJ, Winder NM, Chen M, Giridharan T, Olejniczak SH, et al. \u03b2-adrenergic signaling blocks murine CD8\u2009+\u2009T-cell metabolic reprogramming during activation: A mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68(1):11\u201322. https:\/\/doi.org\/10.1007\/s00262-018-2243-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1526_CR168","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1158\/2326-6066.CIR-20-0445","volume":"9","author":"G Qiao","year":"2021","unstructured":"Qiao G, Chen M, Mohammadpour H, MacDonald CR, Bucsek MJ, Hylander BL, et al. Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor microenvironment. Cancer Immunol Res. 2021;9(6):651\u201364. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0445. PubMed PMID: 33762351; PubMed Central PMCID: PMC8355045.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1526_CR169","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jaci.2023.10.026","volume":"153","author":"JM Reel","year":"2024","unstructured":"Reel JM, Abbadi J, Cox MA. T cells at the interface of neuroimmune communication. J Allergy Clin Immunol. 2024;153(4):894\u2013903. https:\/\/doi.org\/10.1016\/j.jaci.2023.10.026.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1526_CR170","doi-asserted-by":"publisher","first-page":"2306128","DOI":"10.1002\/advs.202306128","volume":"11","author":"W Ren","year":"2024","unstructured":"Ren W, Hua M, Cao F, Zeng W. The sympathetic-immune milieu in metabolic health and diseases: Insights from pancreas, liver, intestine, and adipose tissues. Adv Sci. 2024;11(8):2306128. https:\/\/doi.org\/10.1002\/advs.202306128.","journal-title":"Adv Sci"},{"issue":"1","key":"1526_CR171","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1096\/fba","volume":"4","author":"AC Restaino","year":"2021","unstructured":"Restaino AC, Vermeer PD. Neural regulations of the tumor microenvironment. FASEB Bioadv. 2021;4(1):29\u201342. https:\/\/doi.org\/10.1096\/fba. 2021-00066 PubMed PMID: 35024571; PubMed Central PMCID: PMC8728107.","journal-title":"FASEB Bioadv"},{"key":"1526_CR172","doi-asserted-by":"publisher","first-page":"100867","DOI":"10.1016\/j.bbih.2024.100867","volume":"42","author":"I Ricon-Becker","year":"2024","unstructured":"Ricon-Becker I, Cole SW. Transcriptomics and psychotherapy: An integrative review. Brain, Behavior. Immun - Health. 2024;42:100867. https:\/\/doi.org\/10.1016\/j.bbih.2024.100867.","journal-title":"Immun - Health"},{"issue":"6","key":"1526_CR173","doi-asserted-by":"publisher","first-page":"109863","DOI":"10.1016\/j.isci.2024.109863","volume":"27","author":"I Romero-Carrami\u00f1ana","year":"2024","unstructured":"Romero-Carrami\u00f1ana I, Dominguez-Zorita S, Esparza-Molt\u00f3 PB, Cuezva JM. Ablation of Atp5if1 impairs metabolic reprogramming and proliferation of T lymphocytes and compromises mouse survival. iScience. 2024;27(6):109863. https:\/\/doi.org\/10.1016\/j.isci.2024.109863.","journal-title":"iScience"},{"key":"1526_CR174","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbi.2019.04","volume":"80","author":"KM Rosenberg","year":"2019","unstructured":"Rosenberg KM, Singh NJ. Mouse T cells express a neurotransmitter-receptor signature that is quantitatively modulated in a subset and activation dependent manner. Brain Behav Immun. 2019;80:275\u201385. https:\/\/doi.org\/10.1016\/j.bbi.2019.04. 002 PubMed PMID: 30953766; PubMed Central PMCID: PMC6660347.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1526_CR175","doi-asserted-by":"publisher","first-page":"108979","DOI":"10.1016\/j.celrep.2021.108979","volume":"35","author":"PT Rudak","year":"2021","unstructured":"Rudak PT, Choi J, Parkins KM, Summers KL, Jackson DN, Foster PJ, et al. Chronic stress physically spares but functionally impairs innate-like invariant T cells. Cell Rep. 2021;35(2):108979. https:\/\/doi.org\/10.1016\/j.celrep.2021.108979.","journal-title":"Cell Rep"},{"issue":"1","key":"1526_CR176","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","volume":"38","author":"M Ruterbusch","year":"2020","unstructured":"Ruterbusch M, Pruner KB, Shehata L, Pepper M. In vivo CD4\u2009+\u2009T cell differentiation and function: Revisiting the Th1\/Th2 paradigm. Annu Rev Immunol. 2020;38(1):705\u201325. https:\/\/doi.org\/10.1146\/annurev-immunol-103019-085803.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1526_CR177","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","volume":"26","author":"VM Sanders","year":"2012","unstructured":"Sanders VM. The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet? Brain. Behav Immun. 2012;26(2):195\u2013200. https:\/\/doi.org\/10.1016\/j.bbi.2011.08.001.","journal-title":"Behav Immun"},{"issue":"23","key":"1526_CR178","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jnci\/dji401","volume":"97","author":"AN Saul","year":"2005","unstructured":"Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, et al. Chronic stress and susceptibility to skin cancer. JNCI: J Natl Cancer Inst. 2005;97(23):1760\u20137. https:\/\/doi.org\/10.1093\/jnci\/dji401.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"1526_CR179","doi-asserted-by":"publisher","unstructured":"Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: A review. Front Pharmacol. 2015;6. https:\/\/doi.org\/10.3389\/fphar.2015.00171.","DOI":"10.3389\/fphar.2015.00171"},{"issue":"1","key":"1526_CR180","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41577-020-0387-1","volume":"21","author":"M Schiller","year":"2021","unstructured":"Schiller M, Ben-Shaanan TL, Rolls A. Neuronal regulation of immunity: Why, how and where? Nat Rev Immunol. 2021;21(1):20\u201336. https:\/\/doi.org\/10.1038\/s41577-020-0387-1.","journal-title":"Nat Rev Immunol"},{"issue":"31","key":"1526_CR181","doi-asserted-by":"publisher","first-page":"eady2643","DOI":"10.1126\/sciadv.ady2643","volume":"11","author":"D Sharma","year":"2025","unstructured":"Sharma D, Kohlbach KA, Maples R, Farrar JD. The \u03b22-adrenergic receptor (Adrb2) entrains circadian gene oscillation and CD8\u2009+\u2009T cell differentiation in response to virus infection. Sci Adv. 2025;11(31):eady2643. https:\/\/doi.org\/10.1126\/sciadv.ady2643.","journal-title":"Sci Adv"},{"issue":"5","key":"1526_CR182","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/med.22110","volume":"45","author":"S Shi","year":"2025","unstructured":"Shi S, Cao Y, Wijtmans M, Vischer HF, Leurs R. Recent developments in the optical control of adrenergic signaling. Med Res Rev. 2025;45(5):1307\u201322. https:\/\/doi.org\/10.1002\/med.22110.","journal-title":"Med Res Rev"},{"issue":"1","key":"1526_CR183","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1038\/ncomms9480","volume":"6","author":"ER Siuda","year":"2015","unstructured":"Siuda ER, McCall JG, Al-Hasani R, Shin G, Il Park S, Schmidt MJ, et al. Optodynamic simulation of \u03b2-adrenergic receptor signalling. Nat Commun. 2015;6(1):8480. https:\/\/doi.org\/10.1038\/ncomms9480.","journal-title":"Nat Commun"},{"issue":"1","key":"1526_CR184","doi-asserted-by":"publisher","first-page":"e2145230","DOI":"10.1001\/jamanetworkopen.2021.45230","volume":"5","author":"S Sivanesan","year":"2022","unstructured":"Sivanesan S, Task\u00e9n KA, Grytli HH. Association of \u03b2-blocker use at time of radical prostatectomy with rate of treatment for prostate cancer recurrence. JAMA Netw Open. 2022;5(1):e2145230. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.45230.","journal-title":"JAMA Netw Open"},{"key":"1526_CR185","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.pharmthera.2023.108397","volume":"245","author":"S Smith","year":"2023","unstructured":"Smith S, Ascione R. Targeting neuro-immune systems to achieve cardiac tissue repair following myocardial infarction: A review of therapeutic approaches from in-vivo preclinical to clinical studies. Pharmacol Ther. 2023;245:108397. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108397.","journal-title":"Pharmacol Ther"},{"issue":"10055","key":"1526_CR186","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet"},{"issue":"1","key":"1526_CR187","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-019-1632-z","volume":"16","author":"S Sugama","year":"2019","unstructured":"Sugama S, Takenouchi T, Hashimoto M, Ohata H, Takenaka Y, Kakinuma Y. Stress-induced microglial activation occurs through \u03b2-adrenergic receptor: noradrenaline as a key neurotransmitter in microglial activation. J Neuroinflammation. 2019;16(1):266. https:\/\/doi.org\/10.1186\/s12974-019-1632-z.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1526_CR189","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/CS20220654","volume":"137","author":"H Sun","year":"2023","unstructured":"Sun H, Song J, Li K, Li Y, Shang L, Zhou Q, et al. Increased \u03b21-adrenergic receptor antibody confers a vulnerable substrate for atrial fibrillation via mediating Ca2\u2009+\u2009mishandling and atrial fibrosis in active immunization rabbit models. Clin Sci (Lond). 2023a;137(2):195\u2013217. CS20220654 PubMed PMID: 36597894; PubMed Central PMCID: PMC9885845.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1526_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Sig Transduct Target Ther. 2023b;8(1):1\u201350. https:\/\/doi.org\/10.1038\/s41392-023-01471-y.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"1526_CR188","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s12967-025-06657-2","volume":"23","author":"C Sun","year":"2025","unstructured":"Sun C, Shen Y, Wang F, Lu T, Zhang J. Sympathetic nervous system in tumor progression and metabolic regulation: Mechanisms and clinical potential. J Translational Med. 2025;23(1):836. https:\/\/doi.org\/10.1186\/s12967-025-06657-2.","journal-title":"J Translational Med"},{"issue":"3","key":"1526_CR192","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1365-2249.1997.4411460.x","volume":"110","author":"S SUZUKI","year":"1997","unstructured":"SUZUKI S, TOYABE S, MORODA T, TADA T, TSUKAHARA A, IIAI T, et al. Circadian rhythm of leucocytes and lymphocyte subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol. 1997;110(3):500\u20138. https:\/\/doi.org\/10.1046\/j.1365-2249.1997.4411460.x.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"1526_CR191","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1084\/jem.20160723","volume":"213","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Hayano Y, Nakai A, Furuta F, Noda M. Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J Exp Med. 2016;213(12):2567\u201374. https:\/\/doi.org\/10.1084\/jem.20160723.","journal-title":"J Exp Med"},{"issue":"2","key":"1526_CR193","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CMR.0000000000000943","volume":"34","author":"B Switzer","year":"2024","unstructured":"Switzer B, Puzanov I, Gandhi S, Repasky EA. Targeting beta-adrenergic receptor pathways in melanoma: How stress modulates oncogenic immunity. Melanoma Res. 2024;34(2):89. https:\/\/doi.org\/10.1097\/CMR.0000000000000943.","journal-title":"Melanoma Res"},{"key":"1526_CR194","doi-asserted-by":"publisher","unstructured":"Tanaka S, Abe C, Abbott SBG, Zheng S, Yamaoka Y, Lipsey JE et al. Vagus nerve stimulation activates two distinct neuroimmune circuits converging in the spleen to protect mice from kidney injury. Proceedings of the National Academy of Sciences. 2021;118(12):e2021758118. https:\/\/doi.org\/10.1073\/pnas.2021758118","DOI":"10.1073\/pnas.2021758118"},{"issue":"8","key":"1526_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00109-021-02080-4","volume":"99","author":"GJA ten Bosch","year":"2021","unstructured":"ten Bosch GJA, Bolk J, \u2018t Hart BA, Laman JD. Multiple sclerosis is linked to MAPKERK overactivity in microglia. J Mol Med. 2021;99(8):1033\u201342. https:\/\/doi.org\/10.1007\/s00109-021-02080-4.","journal-title":"J Mol Med"},{"issue":"8","key":"1526_CR195","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00262-023-03445-z","volume":"72","author":"S Thapa","year":"2023","unstructured":"Thapa S, Cao X. Nervous regulation: Beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases. Cancer Immunol Immunother. 2023;72(8):2549\u201356. https:\/\/doi.org\/10.1007\/s00262-023-03445-z.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"1526_CR197","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000319375","volume":"18","author":"X Tian","year":"2011","unstructured":"Tian X, Zhang L, Hou Y, Xu W, Dong Y, Liu J, et al. Effects of cAMP and \u03b2-adrenergic receptor antagonists on the function of peripheral T helper lymphocytes in patients with heart failure. Neuroimmunomodulation. 2011;18(2):73\u20138. https:\/\/doi.org\/10.1159\/000319375.","journal-title":"Neuroimmunomodulation"},{"key":"1526_CR196","doi-asserted-by":"publisher","first-page":"777018","DOI":"10.3389\/fcell.2021.777018","volume":"9","author":"W Tian","year":"2021","unstructured":"Tian W, Liu Y, Cao C, Zeng Y, Pan Y, Liu X, et al. Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments. Front Cell Dev Biol. 2021;9:777018. https:\/\/doi.org\/10.3389\/fcell.2021.777018.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1526_CR198","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11523-025-01184-y","volume":"20","author":"K Tokunaga","year":"2025","unstructured":"Tokunaga K, Fujiwara Y, Omori R, Sato T, Ahluwalia MS, Mukherjee S. The efficacy and safety of beta-blockers and immune checkpoint inhibitors in patients with cancer: A systematic review and meta-analysis. Target Oncol. 2025;20(6):893\u2013905. https:\/\/doi.org\/10.1007\/s11523-025-01184-y.","journal-title":"Target Oncol"},{"issue":"1","key":"1526_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26010254","volume":"26","author":"HE Trojan","year":"2025","unstructured":"Trojan HE, Rink L, Jakobs J. Zinc deficiency exacerbates lead-induced interleukin-2 suppression by regulating CREM expression. Int J Mol Sci. 2025;26(1):1. https:\/\/doi.org\/10.3390\/ijms26010254.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1526_CR200","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1177\/1352458514528758","volume":"20","author":"CP Tsai","year":"2014","unstructured":"Tsai CP, Lin FC, Lee CTC. Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. Mult Scler. 2014;20(12):1593\u2013601. https:\/\/doi.org\/10.1177\/1352458514528758.","journal-title":"Mult Scler"},{"issue":"3","key":"1526_CR201","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41583-021-00555-4","volume":"23","author":"S Udit","year":"2022","unstructured":"Udit S, Blake K, Chiu IM. Somatosensory and autonomic neuronal regulation of the immune response. Nat Rev Neurosci. 2022;23(3):157\u201371. https:\/\/doi.org\/10.1038\/s41583-021-00555-4.","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"1526_CR203","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1158\/0008-5472.CAN-17-0108","volume":"77","author":"R Udumyan","year":"2017","unstructured":"Udumyan R, Montgomery S, Fang F, Almroth H, Valdimarsdottir U, Ekbom A, et al. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res. 2017;77(13):3700\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0108.","journal-title":"Cancer Res"},{"issue":"8","key":"1526_CR202","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/0284186X.2022.2101902","volume":"61","author":"R Udumyan","year":"2022","unstructured":"Udumyan R, Botteri E, Jerlstrom T, Montgomery S, Smedby KE, Fall K. Beta-blocker use and urothelial bladder cancer survival: A Swedish register-based cohort study. Acta Oncol. 2022;61(8):922\u201330. 2022.2101902 PubMed PMID: 35881046.","journal-title":"Acta Oncol"},{"issue":"5","key":"1526_CR204","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/annonc\/mds","volume":"24","author":"HM Wang","year":"2013","unstructured":"Wang HM, Liao ZX, Komaki R, Welsh JW, O\u2019Reilly MS, Chang JY, et al. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013;24(5):1312\u20139. https:\/\/doi.org\/10.1093\/annonc\/mds. 616 PubMed PMID: 23300016.","journal-title":"Ann Oncol"},{"issue":"6","key":"1526_CR205","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms26062553","volume":"26","author":"Y Wang","year":"2025","unstructured":"Wang Y, Anesi JC, Panicker IS, Cook D, Bista P, Fang Y, et al. Neuroimmune interactions and their role in immune cell trafficking in cardiovascular diseases and cancer. Int J Mol Sci. 2025;26(6):6. https:\/\/doi.org\/10.3390\/ijms26062553.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"1526_CR206","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1002\/cncr.29392","volume":"121","author":"JL Watkins","year":"2015","unstructured":"Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, et al. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015;121(19):3444\u201351. https:\/\/doi.org\/10.1002\/cncr.29392.","journal-title":"Cancer"},{"key":"1526_CR207","doi-asserted-by":"publisher","unstructured":"Wehbi VL, Task\u00e9n K. Molecular mechanisms for cAMP-mediated immunoregulation in T cells \u2013 role of anchored protein kinase a signaling units. Front Immunol. 2016;7. https:\/\/doi.org\/10.3389\/fimmu.2016.00222.","DOI":"10.3389\/fimmu.2016.00222"},{"key":"1526_CR208","doi-asserted-by":"publisher","first-page":"1528363","DOI":"10.3389\/fimmu.2025.1528363","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Li Y, Deng W, Li Z. Central nervous system and immune cells interactions in cancer: Unveiling new therapeutic avenues. Front Immunol. 2025;16:1528363. https:\/\/doi.org\/10.3389\/fimmu.2025.1528363.","journal-title":"Front Immunol"},{"issue":"2","key":"1526_CR209","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-5728(94)00153-F","volume":"56","author":"K Wiegmann","year":"1995","unstructured":"Wiegmann K, Muthyala S, Kim DH, Arnason BGW, Chelmicka-Schorr E. \u03b2-adrenergic agonists suppress chronic\/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol. 1995;56(2):201\u20136. https:\/\/doi.org\/10.1016\/0165-5728(94)00153-F.","journal-title":"J Neuroimmunol"},{"key":"1526_CR210","doi-asserted-by":"publisher","unstructured":"Wik JA, Sk\u00e5lhegg BS. T cell metabolism in infection. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.840610.","DOI":"10.3389\/fimmu.2022.840610"},{"key":"1526_CR211","doi-asserted-by":"publisher","unstructured":"Wu L, Tai Y, Hu S, Zhang M, Wang R, Zhou W, et al. Bidirectional role of \u03b22-adrenergic receptor in autoimmune diseases. Front Pharmacol. 2018;9. https:\/\/doi.org\/10.3389\/fphar.2018.01313.","DOI":"10.3389\/fphar.2018.01313"},{"issue":"8","key":"1526_CR212","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41590-023-01529-7","volume":"24","author":"VH Wu","year":"2023","unstructured":"Wu VH, Yung BS, Faraji F, Saddawi-Konefka R, Wang Z, Wenzel AT, et al. The GPCR\u2013g\u03b1s\u2013PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure. Nat Immunol. 2023a;24(8):1318\u201330. https:\/\/doi.org\/10.1038\/s41590-023-01529-7.","journal-title":"Nat Immunol"},{"key":"1526_CR213","doi-asserted-by":"publisher","unstructured":"Wu YL, van Hyfte G, \u00d6zbek U, Reincke M, Gampa A, Mohamed YI, et al. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Front Oncol. 2023b;13. https:\/\/doi.org\/10.3389\/fonc.2023.1128569.","DOI":"10.3389\/fonc.2023.1128569"},{"issue":"3","key":"1526_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1209-2","volume":"10","author":"W Xu","year":"2019","unstructured":"Xu W, Wu Y, Wang L, Bai Y, Du Y, Li Y, et al. Autoantibody against \u03b21-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4\u2009+\u2009T cells by up-regulating AMPK-mediated fatty acid oxidation. Cell Death Dis. 2019;10(3):1\u201313. https:\/\/doi.org\/10.1038\/s41419-018-1209-2.","journal-title":"Cell Death Dis"},{"key":"1526_CR215","doi-asserted-by":"publisher","first-page":"109383","DOI":"10.1016\/j.intimp.2022.109383","volume":"113","author":"X Yan","year":"2022","unstructured":"Yan X, Liu P, Li D, Hu R, Tao M, Zhu S, et al. Novel evidence for the prognostic impact of \u03b2-blockers in solid cancer patients receiving immune checkpoint inhibitors. Int Immunopharmacol. 2022;113:109383. https:\/\/doi.org\/10.1016\/j.intimp.2022.109383.","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"1526_CR216","doi-asserted-by":"publisher","first-page":"2207029","DOI":"10.1002\/smll.202207029","volume":"19","author":"C Yang","year":"2023","unstructured":"Yang C, He Y, Chen F, Zhang F, Shao D, Wang Z. Leveraging \u03b2-adrenergic receptor signaling blockade for improved cancer immunotherapy through biomimetic nanovaccine. Small. 2023;19(14):2207029. https:\/\/doi.org\/10.1002\/smll.202207029.","journal-title":"Small"},{"issue":"4","key":"1526_CR217","doi-asserted-by":"publisher","first-page":"104023","DOI":"10.1016\/j.autrev.2026.104023","volume":"25","author":"J Ye","year":"2026","unstructured":"Ye J, Lan Y, Li W, Lv H, Wen C, Xu Z. Vagus nerve stimulation in autoimmune diseases: Mechanisms, therapeutic potential, and clinical applications. Autoimmun rev. 2026;25(4):104023. https:\/\/doi.org\/10.1016\/j.autrev.2026.104023.","journal-title":"Autoimmun rev"},{"issue":"21","key":"1526_CR218","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.neuron.2022.10.014","volume":"110","author":"Z You","year":"2022","unstructured":"You Z, Liu B, Qi H. Neuronal regulation of B-cell immunity: Anticipatory immune posturing? Neuron. 2022;110(21):3582\u201396. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.014.","journal-title":"Neuron"},{"issue":"5","key":"1526_CR219","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.clpt.6100154","volume":"81","author":"XY Yu","year":"2007","unstructured":"Yu XY, Lin SG, Wang XM, Liu Y, Zhang B, Lin QX, et al. Evidence for coexistence of three \u03b2-adrenoceptor subtypes in human peripheral lymphocytes. Clin Pharmacol Ther. 2007;81(5):654\u20138. https:\/\/doi.org\/10.1038\/sj.clpt.6100154.","journal-title":"Clin Pharmacol Ther"},{"issue":"23","key":"1526_CR220","doi-asserted-by":"publisher","first-page":"2306772","DOI":"10.1002\/advs.202306772","volume":"11","author":"Y Yu","year":"2024","unstructured":"Yu Y, Chen W, Li B, Li Z, Wang Y, Mao Y, et al. Cutaneous Calcium\/Calmodulin-Dependent Protein Kinase II-\u03b3\u2013Positive Sympathetic Nerves Secreting Norepinephrine Dictate Psoriasis. Adv Sci. 2024;11(23):2306772. https:\/\/doi.org\/10.1002\/advs.202306772.","journal-title":"Adv Sci"},{"key":"1526_CR221","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.intimp.2021.107709","volume":"97","author":"K Yuki","year":"2021","unstructured":"Yuki K. The immunomodulatory mechanism of dexmedetomidine. Int Immunopharmacol. 2021;97:107709. https:\/\/doi.org\/10.1016\/j.intimp.2021.107709.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1526_CR225","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.115.017472","volume":"133","author":"W Zhang","year":"2016","unstructured":"Zhang W, Qu X, Chen B, Snyder M, Wang M, Li B, et al. Critical roles of STAT3 in \u03b2-adrenergic functions in the heart. Circulation. 2016;133(1):48\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017472.","journal-title":"Circulation"},{"issue":"1","key":"1526_CR226","doi-asserted-by":"publisher","first-page":"1957605","DOI":"10.1080\/2162402X.2021.1957605","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen H, Chen S, Li Z, Chen J, Li W. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis. OncoImmunology. 2021;10(1):1957605. 2021.1957605 PubMed PMID: 34377596.","journal-title":"OncoImmunology"},{"issue":"1","key":"1526_CR224","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-022-02439-6","volume":"41","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang W, Li Z, Lin S, Zheng T, Hao B, et al. Mitochondria dysfunction in CD8\u2009+\u2009T cells as an important contributing factor for cancer development and a potential target for cancer treatment: A review. J Experimental Clin Cancer Res. 2022;41(1):227. https:\/\/doi.org\/10.1186\/s13046-022-02439-6.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"7","key":"1526_CR222","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jtha.2023.02.030","volume":"21","author":"GC Zhang","year":"2023","unstructured":"Zhang GC, Wu YJ, Liu FQ, Chen Q, Sun XY, Qu QY, et al. \u03b22-adrenergic receptor agonist corrects immune thrombocytopenia by reestablishing the homeostasis of T cell differentiation. J Thromb Haemost. 2023;21(7):1920\u201333. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.030. PubMed PMID: 36972787.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1526_CR223","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Liu J, Chen J, Wang J, Hua H, et al. cAMP-PKA\/EPAC signaling and cancer: The interplay in tumor microenvironment. J Hematol Oncol. 2024;17(1):5. https:\/\/doi.org\/10.1186\/s13045-024-01524-x.","journal-title":"J Hematol Oncol"},{"key":"1526_CR227","doi-asserted-by":"publisher","unstructured":"Zhang Y, Yu F, Ouyang J, Liu P, Dai Y, Wang Y, et al. ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function. J Immunother Cancer. 2025;13(6). https:\/\/doi.org\/10.1136\/jitc-2025-011611. PubMed PMID:.","DOI":"10.1136\/jitc-2025-011611"},{"issue":"7965","key":"1526_CR228","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","volume":"618","author":"J Zhu","year":"2023","unstructured":"Zhu J, Naulaerts S, Boudhan L, Martin M, Gatto L, Van Den Eynde BJ. Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors. Nature. 2023;618(7965):607\u201315. https:\/\/doi.org\/10.1038\/s41586-023-06110-8.","journal-title":"Nature"},{"issue":"2","key":"1526_CR229","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ehf2.14293","volume":"10","author":"E Zweck","year":"2023","unstructured":"Zweck E, Karschnia M, Scheiber D, Heidecke H, Dechend R, Barthuber C, et al. Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure. ESC Heart Fail. 2023;10(2):1258\u201369. https:\/\/doi.org\/10.1002\/ehf2.14293.","journal-title":"ESC Heart Fail"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01526-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:44:14Z","timestamp":1787269454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01526-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":229,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01526-0","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"131"}}